Selective oestrogen receptor (ER) modulators reduce microglia reactivity in vivo after peripheral inflammation: potential role of microglial ERs
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
It has been previously reported that the neuroprotective hormone oestradiol reduces microglia inflammatory activity. The objective of this study was to test whether two selective oestrogen receptor modulators, tamoxifen and raloxifene, modulate in vivo the activation of microglia induced by the peripheral administration of lipopolysaccharide (LPS). Activation of microglia was assessed in the white matter of the cerebellum using immunoreactivity for major histocompatability complex-II. Oestradiol, tamoxifen and raloxifene decreased microglia activation induced by LPS in male and ovariectomized female rats, although the doses of oestradiol that were effective in decreasing microglia reactivity were not the same in both sexes. Tamoxifen reduced microglia activation in all experimental groups at all doses tested (0.5–2 mg/kg b.w.) while raloxifene lost its anti-inflammatory activity at the higher dose tested (2 mg/kg b.w). In addition, raloxifene had per se a moderate pro-inflammatory activity in the brain of control female rats and its anti-inflammatory activity was partially impaired in female animals after 1 month of deprivation of ovarian hormones. Spots of oestrogen receptor (ER)-α immunoreactivity were detected in the soma and cell processes of microglia. Treatment with LPS, oestradiol or tamoxifen induced an increase of ER-α immunoreactive spots in the perikaryon of microglia, while oestradiol antagonized the effect of LPS. The results indicate that some oestrogenic compounds decrease brain inflammation by a mechanism that may involve ERs expressed by microglia. The findings support the potential therapeutic role of oestrogenic compounds as protective anti-inflammatory agents for the central nervous system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
Molecular basis of agonism and antagonism in the oestrogen receptor
Brzozowski, A. M., Pike, A. C. W., Dauter, Z., Hubbard, R. E., Bonn, T., Engström, O., Öhman, L., Greene, G. L., Gustafsson, J.-Å., & Carlquist, M. (1997) · Nature · doi:10.1038/39645 · Cited by 3,355
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144 · cited 1×
“The systemic proinflammatory cytokines, such as tumour necrosis factor-a, are critical for the transfer of the peripheral inflammation induced by LPS to the central nervous system (Qin et al. 2007).”
BackgroundAstrocyte activation and reactive gliosis
Pekny, M., & Nilsson, M. (2005) · Glia · doi:10.1002/glia.20207 · Cited by 1,611
Combinatorial Control of Gene Expression by Nuclear Receptors and Coregulators
McKenna, N. J., & O'Malley, B. W. (2002) · Cell · doi:10.1016/s0092-8674(02)00641-4 · Cited by 1,463 · cited 1×
“The activity of ERs is regulated by their association with transcriptional cofactors that have a tissue- or cell-specific expression (Klinge 2000, McKenna & O’Malley 2002, Belandia & Parker 2003).”
Streit, W. J., Walter, S. A., & Pennell, N. A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00069-0 · Cited by 1,096
Cunningham, C., Wilcockson, D. C., Campion, S., Lunnon, K., & Perry, V. H. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2614-05.2005 · Cited by 768
Microglia derived from aging mice exhibit an altered inflammatory profile
Sierra, A., Gottfried‐Blackmore, A. C., McEwen, B. S., & Bulloch, K. (2007) · Glia · doi:10.1002/glia.20468 · Cited by 688
Layé, S., Parnet, P., Goujon, E., & Dantzer, R. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90197-x · Cited by 500
The impact of systemic infection on the progression of neurodegenerative disease
Perry, V. H., Newman, T. A., & Cunningham, C. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1032 · Cited by 428
Cited by
Gillies, G. E., & McArthur, S. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002071 · Cited by 733
“Although this work is almost exclusively done in female subjects, a recent study reported that there are sex differences in the doses of estradiol, tamoxifen, and raloxifene required to suppress microglial activation induced by bacterial lipopolysaccharide (Tapia-Gonzalez et al., 2008).”
BackgroundThe neuroprotective actions of oestradiol and oestrogen receptors
Arevalo, M.-A., Azcoitia, I., & Garcia-Segura, L. M. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3856 · Cited by 480
Self-citationEstrogens, Neuroinflammation, and Neurodegeneration
Villa, A., Vegeto, E., Poletti, A., & Maggi, A. (2016) · Endocrine Reviews · doi:10.1210/er.2016-1007 · Cited by 423
Taves, S., Berta, T., Liu, D.-L., Gan, S., Chen, G., Kim, Y. H., Van de Ven, T., Laufer, S., & Ji, R.-R. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.10.006 · Cited by 316
Toll-like receptors in chronic pain
Nicotra, L., Loram, L. C., Watkins, L. R., & Hutchinson, M. R. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.038 · Cited by 250
“Both the estrogen receptor alpha and beta (ERα, ERβ), and the recently identified GPR30 membrane receptors are present on most cells within the CNS including microglia and astrocytes (Azcoitia et al., 1999; Baker et al., 2004; Blurton-Jones and Tuszynski, 2001; Tapia-Gonzalez et al., 2008).”
BackgroundDiz-Chaves, Y., Pernía, O., Carrero, P., & Garcia-Segura, L. M. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-71 · Cited by 230
“The effect of prenatal stress was assessed, under basal conditions and after an immune challenge caused by the systemic administration of LPS, in female mice that were ovariectomized to eliminate the neuroprotective and anti-inflammatory action of ovarian hormones [34-36].”
BackgroundSelf-citationActions of estrogens on glial cells: Implications for neuroprotection
Arevalo, M.-A., Santos-Galindo, M., Bellini, M.-J., Azcoitia, I., & Garcia-Segura, L. M. (2010) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.10.002 · Cited by 214
Self-citationCerciat, M., Unkila, M., Garcia‐Segura, L. M., & Arevalo, M. ‐. (2010) · Glia · doi:10.1002/glia.20904 · Cited by 160
“In addition, estradiol may also promote neuroprotection by reducing the activation of microglia and the release of cytokines by reactive microglia (Barreto et al., 2007; Suuronen et al., 2005; Tapia-Gonzalez et al., 2008; Vegeto et al., 2003, 2006, 2008).”
BackgroundSelf-citationAcosta-Martínez, M. (2020) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.264598 · Cited by 51
“In the rat cerebellum, punctiform ERa but not ERb immunostaining was observed in the soma and cell processes of microglia, and treatment with LPS, E2, or tamoxifen increased ERa punctiform immunostaining in the microglial perikaryon (Tapia-Gonzalez et al., 2008).”
BackgroundMethodInfluentialTamoxifen Promotes Axonal Preservation and Gait Locomotion Recovery after Spinal Cord Injury in Cats
de la Torre Valdovinos, B., Duenas Jimenez, J. M., Estrada, I. J., Banuelos Pineda, J., Franco Rodriguez, N. E., Lopez Ruiz, J. R., Osuna Carrasco, L. P., Candanedo Arellano, A., & Duenas Jimenez, S. H. (2016) · Journal of Veterinary Medicine · doi:10.1155/2016/9561968 · Cited by 16
Metadata
- Authors
- Tapia-Gonzalez, S., Carrero, P., Pernia, O., Garcia-Segura, L. M., & Diz-Chaves, Y.
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2008-05-07
- Volume
- 198
- Issue
- 1
- Pages
- 219-230
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2098833893
- Cited by
- 100
- References
- 15
- FWCI
- 5.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.